{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:46:56Z","timestamp":1793641616337,"version":"4.5.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.atherosclerosis.2021.09.007","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T02:40:24Z","timestamp":1631155224000},"page":"110-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Chronic kidney disease measures for cardiovascular risk prediction"],"prefix":"10.1016","volume":"335","author":[{"given":"Yejin","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-3764","authenticated-orcid":false,"given":"Shoshana H.","family":"Ballew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.atherosclerosis.2021.09.007_bib3","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease","volume":"308","author":"Hallan","year":"2012","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ki.2013.553","article-title":"Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar","volume":"86","author":"Wen","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib9","doi-asserted-by":"crossref","first-page":"f324","DOI":"10.1136\/bmj.f324","article-title":"Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis","volume":"346","author":"Nitsch","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib10","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","article-title":"Serum creatinine as an index of renal function: new insights into old concepts","volume":"38","author":"Perrone","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight - reconsidering the use of race correction in clinical algorithms","volume":"383","author":"Vyas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.2019.5774","article-title":"Reconsidering the consequences of using race to estimate kidney function","volume":"322","author":"Eneanya","year":"2019","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2215\/CJN.12791019","article-title":"Kidney disease, race, and GFR estimation","volume":"15","author":"Levey","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1373\/clinchem.2004.044388","article-title":"A marker of renal function or something more?","volume":"51","author":"Curhan","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib15","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.07.060","article-title":"Cystatin-C and inflammatory markers in the ambulatory elderly","volume":"118","author":"Shlipak","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S2213-8587(17)30183-3","article-title":"Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data","volume":"5","author":"Matsushita","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1258\/acb.2009.009007","article-title":"How should proteinuria be detected and measured?","volume":"46","author":"Lamb","year":"2009","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/M20-0529","article-title":"Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis : an individual participant-based meta-analysis","volume":"173","author":"Sumida","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib22","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2018.08.043","article-title":"Chronic kidney disease measures and the risk of abdominal aortic aneurysm","volume":"279","author":"Matsushita","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.ackd.2014.06.007","article-title":"The interplay between CKD, sudden cardiac death, and ventricular arrhythmias","volume":"21","author":"Pun","year":"2014","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib26","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/ndt\/gfq179","article-title":"Chronic kidney disease and venous thromboembolism: a prospective study","volume":"25","author":"Folsom","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.2007030308","article-title":"Chronic kidney disease increases risk for venous thromboembolism","volume":"19","author":"Wattanakit","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib31","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.ekir.2020.07.029","article-title":"Impact of CKD progression on cardiovascular disease risk in a contemporary UK cohort of individuals with diabetes","volume":"5","author":"Cabrera","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/5584_2016_84","article-title":"Hypertension in chronic kidney disease","volume":"956","author":"Hamrahian","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib33","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1161\/STROKEAHA.109.550707","article-title":"Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study","volume":"40","author":"Kokubo","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000337821","article-title":"Lipid disorders in uremia and dialysis","volume":"178","author":"Bakris","year":"2012","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002922","article-title":"Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed","volume":"9","author":"Miller","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"Hung","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006259","article-title":"Kidney disease measures and left ventricular structure and function: the atherosclerosis risk in communities study","volume":"6","author":"Matsushita","year":"2017","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib38","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jacc.2019.01.059","article-title":"Left atrial structure and function, and left ventricular diastolic dysfunction: JACC state-of-the-art review","volume":"73","author":"Thomas","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.med.55.091902.104417","article-title":"Left ventricular diastolic dysfunction and diastolic heart failure","volume":"55","author":"Gaasch","year":"2004","journal-title":"Annu. Rev. Med."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2021.09.007_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/17.suppl_1.29","article-title":"Left ventricular alterations and end-stage renal disease","volume":"17","author":"London","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib41","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamacardio.2019.3113","article-title":"Association between circulating troponin concentrations, left ventricular systolic and diastolic functions, and incident heart failure in older adults","volume":"4","author":"Myhre","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000789","article-title":"Prognostic value of left ventricular diastolic dysfunction in a general population","volume":"3","author":"Kuznetsova","year":"2014","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: a new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","article-title":"Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification","volume":"98","author":"Li","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib46","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib49","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ahj.2014.04.017","article-title":"Parathyroid hormone concentration and risk of cardiovascular diseases: the Atherosclerosis Risk in Communities (ARIC) study","volume":"168","author":"Folsom","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib50","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1210\/jc.2016-3743","article-title":"Physical activity, vitamin D, and incident atherosclerotic cardiovascular disease in whites and blacks: the ARIC study","volume":"102","author":"Chin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib51","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib52","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40620-018-0502-6","article-title":"Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice","volume":"31","author":"De Nicola","year":"2018","journal-title":"J. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.ackd.2017.06.004","article-title":"Hyperkalemia and hypokalemia in CKD: prevalence, risk factors, and clinical outcomes","volume":"24","author":"Gilligan","year":"2017","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/j.ackd.2017.06.002","article-title":"Regulation of potassium homeostasis in CKD","volume":"24","author":"DuBose","year":"2017","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.krcp.2016.02.001","article-title":"Changes in urinary potassium excretion in patients with chronic kidney disease","volume":"35","author":"Ueda","year":"2016","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib57","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: JACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2215\/CJN.05850809","article-title":"Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study","volume":"5","author":"Korgaonkar","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/toxins6020665","article-title":"Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients","volume":"6","author":"Ito","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib60","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib61","volume":"vol. 13","author":"Lim","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib62","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005022","article-title":"Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease","volume":"6","author":"Hung","year":"2017","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib63","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","article-title":"Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study","volume":"27","author":"Wu","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","article-title":"Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease","volume":"43","author":"Lin","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib65","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Asymmetrical dimethylarginine: the Uber marker?","volume":"109","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ajkd.2016.10.033","article-title":"Serum asymmetric and symmetric dimethylarginine and morbidity and mortality in hemodialysis patients","volume":"70","author":"Shafi","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib67","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/01.hjh.0000182528.59687.d1","article-title":"The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease","volume":"23","author":"Testa","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib68","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","article-title":"Association of kidney function with anemia: the third national health and nutrition examination survey (1988-1994)","volume":"162","author":"Astor","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"Suppl 3","key":"10.1016\/j.atherosclerosis.2021.09.007_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.ndt.a027970","article-title":"Pathophysiology of anaemia: focus on the heart and blood vessels","volume":"15","author":"Metivier","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib70","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/HJH.0b013e3280f9df97","article-title":"Haematocrit levels and left ventricular geometry: results of the MONICA Augsburg Echocardiographic Substudy","volume":"25","author":"Stritzke","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib71","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ahj.2005.03.055","article-title":"Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"151","author":"Astor","year":"2006","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007209","article-title":"Hemoglobin, albuminuria, and kidney function in cardiovascular risk: the ARIC (atherosclerosis risk in communities) study","volume":"7","author":"Ishigami","year":"2018","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib73","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front. Biosci."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib74","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000368940","article-title":"Update on inflammation in chronic kidney disease","volume":"39","author":"Akchurin","year":"2015","journal-title":"Blood Purif."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib76","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib77","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ndt\/gfq471","article-title":"Inflammation, kidney function and albuminuria in the Framingham Offspring cohort","volume":"26","author":"Upadhyay","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib78","first-page":"4310379","article-title":"Vascular calcification in chronic kidney disease: the role of inflammation","volume":"2018","author":"Benz","year":"2018","journal-title":"Internet J. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib79","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","article-title":"Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients","volume":"216","author":"Recio-Mayoral","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148189","article-title":"Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: findings from the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib81","first-page":"137","article-title":"Association of glomerular filtration rate and inflammation with left ventricular hypertrophy in chronic kidney disease patients","volume":"16","author":"Dervisoglu","year":"2012","journal-title":"Hippokratia"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124772","article-title":"Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study","volume":"10","author":"Gupta","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib83","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ajh\/hpw164","article-title":"Inflammation and arterial stiffness in chronic kidney disease: findings from the CRIC study","volume":"30","author":"Peyster","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.ajkd.2018.09.012","article-title":"Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study","volume":"73","author":"Amdur","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib85","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib86","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib87","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib88","doi-asserted-by":"crossref","first-page":"3081856","DOI":"10.1155\/2017\/3081856","article-title":"Oxidative stress in hemodialysis patients: a review of the literature","volume":"2017","author":"Liakopoulos","year":"2017","journal-title":"Oxid. Med. Cell Longev"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2019.12.006","article-title":"Oxidative stress contributes to vascular calcification in patients with chronic kidney disease","volume":"138","author":"Huang","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib90","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2016","key":"10.1016\/j.atherosclerosis.2021.09.007_bib91","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib92","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib93","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ekir.2019.12.011","article-title":"High prevalence and low awareness of albuminuria in the community setting in the KDSAP","volume":"5","author":"Zhuo","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib94","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/STROKEAHA.115.009861","article-title":"Proteinuria, but not eGFR, predicts stroke risk in chronic kidney disease: chronic renal insufficiency cohort study","volume":"46","author":"Sandsmark","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib95","article-title":"ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"2021","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib96","doi-asserted-by":"crossref","first-page":"100552","DOI":"10.1016\/j.eclinm.2020.100552","article-title":"Incorporating kidney disease measures into cardiovascular risk prediction: development and validation in 9 million adults from 72 datasets","volume":"27","author":"Matsushita","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib97","article-title":"Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"2021","author":"Pearson","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib98","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"Improving global outcomes lipid guideline development work group, M, KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib99","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1253\/circj.CJ-19-0320","article-title":"Novel \"predictor Patch\" method for adding predictors using Estimates from outside datasets- A proof-of-concept study adding kidney measures to cardiovascular mortality prediction","volume":"83","author":"Matsushita","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100552","article-title":"Incorporating Kidney Disease Measures into Cardiovascular Risk Prediction: Development and Validation in 9 Million Adults from 72 Datasets","author":"Matsushita","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib101","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.1996.03530410036030","article-title":"Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project","volume":"275","author":"Normand","year":"1996","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib102","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib103","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2005.01.041","article-title":"Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score","volume":"45","author":"Halkin","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCOUTCOMES.109.854877","article-title":"A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib106","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010546","article-title":"Albuminuria as a predictor of cardiovascular outcomes in patients with acute myocardial infarction","volume":"8","author":"Mok","year":"2019","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib107","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/euhj.2000.2582","article-title":"Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality","volume":"22","author":"Berton","year":"2001","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-012-0853-0","article-title":"Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy","volume":"36","author":"Nazer","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2016.04.013","article-title":"Albuminuria and cardiovascular events in patients with acute coronary syndromes: results from the TRACER trial","volume":"178","author":"Akerblom","year":"2016","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib110","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib111","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib112","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib113","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/ehv028","article-title":"Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial","volume":"36","author":"Cannon","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib114","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib116","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2021.09.007_bib117","first-page":"S60","article-title":"Cardiovascular disease and risk management","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib118","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib119","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-2715","article-title":"Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. Health care organizations","author":"Stempniewicz","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib120","series-title":"National Institute for Health and Care Excellence Guideline for Chronic Kidney Disease","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib121","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3122\/jabfm.2016.05.160020","article-title":"Use of clinical decision support to improve primary care identification and management of chronic kidney disease (CKD)","volume":"29","author":"Litvin","year":"2016","journal-title":"J. Am. Board Fam. Med."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib122","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2021.09.007_bib123","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.09.007_bib124","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney inter, Suppl."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.09.007_bib125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jacc.2021.04.089","article-title":"Albuminuria and prognosis among individuals with atherosclerotic cardiovascular disease","volume":"78","author":"Mok","year":"2021","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021013344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021013344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:49:02Z","timestamp":1758156542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021013344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":125,"alternative-id":["S0021915021013344"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.007","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease measures for cardiovascular risk prediction","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}